New Weight Loss Drug Could Beat Ozempic’s Results—When It’s Coming
A new experimental weight loss drug from Eli Lilly could produce greater weight loss results than popular medications…
Forget Zepbound: Eli Lilly’s Next Billion-Dollar Weight-Loss Drug May Be Even Better
Eli Lilly (NYSE: LLY) has been posting incredible sales and earnings growth in recent quarters, thanks in no…
Eli Lilly Drug Retatrutide Clinical Trial Results
Eli Lilly just announced phase 3 clinical trial results for its new medication, retatrutide, and it could become…
aTyr Pharma’s Phase 3 Sarcoidosis Drug Misses Primary Endpoint
aTyr Pharma (Nasdaq: ATYR) announced topline results from its Phase…
MIPLYFFA Shows 5-Year Disease Stability in Niemann-Pick Type C Treatment Study
Zevra Therapeutics (NASDAQ:ZVRA) announced the presentation of four posters at…